Intuitive Surgical (NASDAQ:ISRG) Upgraded at Piper Jaffray Companies

Piper Jaffray Companies upgraded shares of Intuitive Surgical (NASDAQ:ISRG) to an overweight rating in a research note published on Wednesday, May 22nd, The Fly reports. The brokerage currently has $610.00 price target on the medical equipment provider’s stock.

Several other brokerages have also recently weighed in on ISRG. Canaccord Genuity reissued a buy rating and set a $575.00 price target (down previously from $610.00) on shares of Intuitive Surgical in a research report on Monday, April 22nd. Citigroup dropped their price target on shares of Intuitive Surgical from $684.00 to $611.00 and set a buy rating for the company in a research report on Tuesday, April 23rd. BidaskClub cut shares of Intuitive Surgical from a strong-buy rating to a buy rating in a research report on Tuesday, April 16th. Royal Bank of Canada set a $560.00 price objective on shares of Intuitive Surgical and gave the stock a hold rating in a report on Thursday, February 28th. Finally, Raymond James upped their price objective on shares of Intuitive Surgical from $600.00 to $630.00 and gave the stock an outperform rating in a report on Monday, April 1st. Two investment analysts have rated the stock with a sell rating, four have issued a hold rating and fourteen have given a buy rating to the company’s stock. Intuitive Surgical currently has a consensus rating of Buy and a consensus price target of $576.82.

Shares of Intuitive Surgical stock traded down $9.06 during trading on Wednesday, reaching $496.54. The company’s stock had a trading volume of 626,380 shares, compared to its average volume of 777,573. Intuitive Surgical has a 52-week low of $430.24 and a 52-week high of $589.32. The stock has a market capitalization of $58.19 billion, a price-to-earnings ratio of 52.32, a price-to-earnings-growth ratio of 4.38 and a beta of 1.06.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, April 18th. The medical equipment provider reported $2.61 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $2.70 by ($0.09). The business had revenue of $974.00 million during the quarter, compared to analysts’ expectations of $975.27 million. Intuitive Surgical had a net margin of 29.78% and a return on equity of 17.33%. Intuitive Surgical’s revenue for the quarter was up 14.9% on a year-over-year basis. During the same period last year, the company posted $2.44 EPS. On average, analysts predict that Intuitive Surgical will post 9.4 earnings per share for the current year.

In related news, VP Jamie Samath sold 130 shares of the stock in a transaction dated Monday, June 10th. The shares were sold at an average price of $500.60, for a total transaction of $65,078.00. Following the sale, the vice president now directly owns 219 shares of the company’s stock, valued at approximately $109,631.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Curet Myriam sold 2,200 shares of the stock in a transaction dated Tuesday, April 23rd. The shares were sold at an average price of $493.26, for a total transaction of $1,085,172.00. Following the sale, the executive vice president now directly owns 3,101 shares in the company, valued at $1,529,599.26. The disclosure for this sale can be found here. Insiders have sold a total of 27,621 shares of company stock worth $13,828,454 over the last three months. 1.70% of the stock is currently owned by insiders.

Several hedge funds and other institutional investors have recently made changes to their positions in the company. HC Financial Advisors Inc. purchased a new position in shares of Intuitive Surgical in the third quarter worth approximately $402,000. Vanguard Group Inc boosted its holdings in shares of Intuitive Surgical by 0.4% in the third quarter. Vanguard Group Inc now owns 8,313,421 shares of the medical equipment provider’s stock worth $4,771,903,000 after buying an additional 29,260 shares during the last quarter. Federated Investors Inc. PA boosted its holdings in shares of Intuitive Surgical by 246.7% in the third quarter. Federated Investors Inc. PA now owns 5,606 shares of the medical equipment provider’s stock worth $3,218,000 after buying an additional 3,989 shares during the last quarter. Shine Investment Advisory Services Inc. bought a new stake in Intuitive Surgical during the 4th quarter worth approximately $75,000. Finally, Clean Yield Group bought a new stake in Intuitive Surgical during the 4th quarter worth approximately $251,000. 85.53% of the stock is currently owned by hedge funds and other institutional investors.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci Surgical System transforms the surgeon's natural hand movements outside the body into corresponding micro-movements inside the patient's body. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures.

See Also: What is a portfolio manager?

The Fly

Analyst Recommendations for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply